The largest database of trusted experimental protocols

2 protocols using geltrex basement membrane

1

Anticancer Drug Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorafenib, nilotinib, sunitinib, imatinib, gefitinib, lapatinib, dasatinib, PD-173074, selumetinib, crizotinib, tofacitinib and pazopanib were purchased from LC Laboratories (Woburn, Massachusetts, USA). Roswell Park Memorial Institute Medium (RPMI) and Geltrex basement membrane was purchased from Life Technologies (North Shore City, New Zealand). Met, P-Met (Y1234/Y1235), SRC, P-SRC (Y416), AKT, P-ATK (S473), cyclin D1, cleaved caspase 3, α-tubulin and EGFR antibodies were purchased from Cell Signaling Technology (Danvers, Massachusetts, USA). β-Tubulin was purchased from Sigma-Aldrich (Auckland, New Zealand).
+ Open protocol
+ Expand
2

Feeder-free hESC UCSF4 Line Derivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hESC line UCSF4 was derived by Dr. Susan Fisher (UCSF), NIH registry number 0044 [Krtolica et al., 2011; Felfly and Klein, 2013] . UCSF4 was grown in feeder-free mTeSR media (STEM-CELL Technologies) with either Matrigel (Corning) or Geltrex basement membrane (Life Technologies). ROCK inhibitor (10 μ M , Selleckchem) was added to the cultures during passaging and was removed after 24 h. Activin A (10 ng/ml, R&D Systems), IGF (200 ng/ml, LONG R3 IGF-1, Sigma), and nucleosides (EmbroMax Nu-cleosides, Millipore) were added to cell cultures for 5 days before analysis. Aphidicolin (Fisher Scientific) treatment was performed by allowing the cells to attach and grow for 24 h, after which 0.1 or 0.2 μ M Aphidicolin was added for 16 h, followed by a 2-hour release from the drug.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!